ArticleInvestigative ophthalmology & visual science2026
The CXXC1-IGFBP6 Axis Maintains Corneal Epithelial Differentiation via H3K4me3-Dependent Transcriptional Activation.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To define the role and mechanisms of the epigenetic regulator CXXC1 in corneal epithelial cells (CECs) differentiation. Methods: Chromatin remodeling-related gene ontology (GO) modules were integrated with RNA sequencing (RNA-seq) to identify CXXC finger protein 1 (CXXC1) as a candidate epigenetic regulator of CECs differentiation. Loss-of-function studies were performed in limbal stem/progenitor cells (LSCs), followed by air-liquid interface-induced differentiation into CECs. Effects of CXXC1 depletion were assessed by RNA-seq, quantitative real-time PCR, and immunofluorescence. Chromatin immunoprecipitation sequencing (ChIP-seq) for CXXC1 and H3K4me3 was combined with transcriptomics to identify insulin-like growth factor binding protein 6 (IGFBP6) as a direct target. The role and pathological relevance of the CXXC1-IGFBP6 axis were evaluated by IGFBP6 knockdown and in human corneal ulcer tissues. Results: CXXC1 was expressed throughout the corneal epithelium and was markedly upregulated during LSC-to-CEC differentiation. CXXC1 depletion impaired differentiation and reduced expression of CECs markers and key corneal epithelial regulators. ChIP-seq revealed CXXC1 binding at the IGFBP6 locus, coinciding with H3K4me3 enrichment, whereas CXXC1 knockdown reduced both H3K4me3 enrichment and IGFBP6 expression. IGFBP6 knockdown phenocopied CXXC1 loss. Depletion of either gene activated inflammatory, angiogenic, and hypoxia-related gene programs, suggesting abnormal corneal epithelial differentiation and pathological changes. Both proteins were markedly reduced in human corneal ulcer lesions. Conclusions: CXXC1 maintains CECs differentiation through H3K4me3-dependent activation of IGFBP6 and other epithelial regulators. The CXXC1-IGFBP6 axis is associated with pathological changes in corneal ulcer lesions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.